Hutchinson Capital Management Merck & Co., Inc. Transaction History

Hutchinson Capital Management

$486 Million
Q3 2024

A detailed history of Hutchinson Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hutchinson Capital Management holds 2,111 shares of MRK stock, worth $203,795. This represents 0.05% of its overall portfolio holdings.

Number of Shares

2,111

Previous 2,049 3.03%

Holding current value

$203,795

Previous $253,000 5.53%

% of portfolio

0.05%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$111.15 - $128.97 $6,891 - $7,996	62 Added 3.03%	2,111 $239,000
Q2 2024 Aug 07, 2024	SELL	$123.8 - $132.96 $2,228 - $2,393	-18 Reduced 0.87%	2,049 $253,000
Q1 2024 May 06, 2024	BUY	$113.24 - $131.95 $1,132 - $1,319	10 Added 0.49%	2,067 $272,000
Q4 2023 Feb 07, 2024	SELL	$100.18 - $109.02 $3,105 - $3,379	-31 Reduced 1.48%	2,057 $224,000
Q3 2023 Nov 09, 2023	SELL	$102.95 - $114.33 $74,432 - $82,660	-723 Reduced 25.72%	2,088 $214,000
Q2 2023 Jul 25, 2023	BUY	$108.61 - $118.38 $3,041 - $3,314	28 Added 1.01%	2,811 $324,000
Q1 2023 May 04, 2023	SELL	$102.94 - $114.86 $8,749 - $9,763	-85 Reduced 2.96%	2,783 $296,000
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $378,178 - $484,875	-4,325 Reduced 60.13%	2,868 $318,000
Q3 2022 Oct 31, 2022	SELL	$84.53 - $94.96 $28,740 - $32,286	-340 Reduced 4.51%	7,193 $619,000
Q2 2022 Aug 12, 2022	BUY	$83.49 - $94.64 $6,178 - $7,003	74 Added 0.99%	7,533 $687,000
Q1 2022 May 11, 2022	SELL	$73.51 - $82.4 $7.47 Million - $8.37 Million	-101,637 Reduced 93.16%	7,459 $612,000
Q4 2021 Feb 14, 2022	SELL	$72.28 - $90.54 $98,662 - $123,587	-1,365 Reduced 1.24%	109,096 $8.36 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $144,148 - $158,527	-2,011 Reduced 1.79%	110,461 $8.3 Million
Q2 2021 Aug 12, 2021	SELL	$70.31 - $77.77 $3.67 Million - $4.06 Million	-52,184 Reduced 31.69%	112,472 $8.75 Million
Q1 2021 May 07, 2021	SELL	$68.86 - $81.11 $152,938 - $180,145	-2,221 Reduced 1.33%	164,656 $12.7 Million
Q4 2020 Feb 12, 2021	SELL	$71.77 - $79.65 $142,822 - $158,503	-1,990 Reduced 1.18%	166,877 $13.7 Million
Q3 2020 Nov 13, 2020	SELL	$73.18 - $82.95 $440,104 - $498,861	-6,014 Reduced 3.44%	168,867 $14 Million
Q2 2020 Aug 11, 2020	SELL	$70.42 - $80.13 $117,460 - $133,656	-1,668 Reduced 0.94%	174,881 $13.5 Million
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $485,400 - $672,789	7,661 Added 4.54%	176,549 $13.6 Million
Q4 2019 Feb 05, 2020	SELL	$77.58 - $87.54 $295,191 - $333,089	-3,805 Reduced 2.2%	168,888 $15.4 Million
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $321,818 - $350,793	-4,230 Reduced 2.39%	172,693 $14.5 Million
Q2 2019 Aug 06, 2019	SELL	$69.84 - $81.59 $466,112 - $544,531	-6,674 Reduced 3.64%	176,923 $14.8 Million
Q1 2019 May 06, 2019	SELL	$69.58 - $79.36 $216,532 - $246,968	-3,112 Reduced 1.67%	183,597 $15.3 Million
Q4 2018 Jan 30, 2019	SELL	$65.24 - $75.71 $131,393 - $152,479	-2,014 Reduced 1.07%	186,709 $14.3 Million
Q3 2018 Oct 31, 2018	SELL	$57.69 - $67.84 $4.09 Million - $4.81 Million	-70,880 Reduced 27.3%	188,723 $13.4 Million
Q2 2018 Aug 08, 2018	SELL	$50.83 - $59.72 $187,613 - $220,426	-3,691 Reduced 1.4%	259,603 $15.8 Million
Q1 2018 May 10, 2018	SELL	$50.96 - $59.23 $110,328 - $128,232	-2,165 Reduced 0.82%	263,294 $14.3 Million
Q4 2017 Feb 09, 2018	SELL	$51.62 - $61.64 $104,891 - $125,252	-2,032 Reduced 0.76%	265,459 $14.9 Million
Q3 2017 Oct 30, 2017	BUY	$58.67 - $63.13 $15.7 Million - $16.9 Million	267,491	267,491 $17.1 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $245B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hutchinson Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hutchinson Capital Management with notifications on news.

Account

Hutchinson Capital Management Merck & Co., Inc. Transaction History